Mumps virus surface antigens — Drug Target
All drugs that target Mumps virus surface antigens — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Marketed (1)
- Mumps vaccine · Sinovac (Dalian) Vaccine Technology Co., Ltd. · Live attenuated vaccine · Immunology / Infectious Disease
The mumps vaccine stimulates the immune system to produce antibodies and cellular immunity against the mumps virus, preventing infection and disease.